These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 16388518)

  • 1. Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.
    Garcia-Aranda C; de Juan C; Diaz-Lopez A; Sanchez-Pernaute A; Torres AJ; Diaz-Rubio E; Balibrea JL; Benito M; Iniesta P
    Cancer; 2006 Feb; 106(3):541-51. PubMed ID: 16388518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.
    Gertler R; Rosenberg R; Stricker D; Friederichs J; Hoos A; Werner M; Ulm K; Holzmann B; Nekarda H; Siewert JR
    J Clin Oncol; 2004 May; 22(10):1807-14. PubMed ID: 15143073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
    Engelhardt M; Drullinsky P; Guillem J; Moore MA
    Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas.
    Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Haruma K; Chayama K; Yasui W; Tahara E
    Int J Oncol; 2001 Sep; 19(3):507-12. PubMed ID: 11494028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
    Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher HI; Reuter V; Moore MA
    Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of telomere shelterin by TRF1 [corrected] and TRF2 interacts with telomerase to maintain the telomere length in non-small cell lung cancer.
    Hsu CP; Ko JL; Shai SE; Lee LW
    Lung Cancer; 2007 Dec; 58(3):310-6. PubMed ID: 17681636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomere shortening and the clinicopathologic characteristics of human colorectal carcinomas.
    Takagi S; Kinouchi Y; Hiwatashi N; Chida M; Nagashima F; Takahashi S; Negoro K; Shimosegawa T; Toyota T
    Cancer; 1999 Oct; 86(8):1431-6. PubMed ID: 10526269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomere length and telomerase subunits as diagnostic and prognostic biomarkers in Barrett carcinoma.
    Gertler R; Doll D; Maak M; Feith M; Rosenberg R
    Cancer; 2008 May; 112(10):2173-80. PubMed ID: 18348304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between telomerase expression and terminal restriction fragment length ratio in non-small cell lung cancer--an adjusted measurement and its clinical significance.
    Hsu CP; Miaw J; Shai SE; Chen CY
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):425-31. PubMed ID: 15296909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma.
    Gertler R; Rosenberg R; Stricker D; Werner M; Lassmann S; Ulm K; Nekarda H; Siewert JR
    Cancer; 2002 Nov; 95(10):2103-11. PubMed ID: 12412163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase activity and alterations in telomere length in human brain tumors.
    Hiraga S; Ohnishi T; Izumoto S; Miyahara E; Kanemura Y; Matsumura H; Arita N
    Cancer Res; 1998 May; 58(10):2117-25. PubMed ID: 9605755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical usefulness of telomerase activation and telomere length in head and neck cancer.
    Patel MM; Parekh LJ; Jha FP; Sainger RN; Patel JB; Patel DD; Shah PM; Patel PS
    Head Neck; 2002 Dec; 24(12):1060-7. PubMed ID: 12454944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of telomere length by the human telomeric protein TRF1.
    van Steensel B; de Lange T
    Nature; 1997 Feb; 385(6618):740-3. PubMed ID: 9034193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer.
    Tatsumoto N; Hiyama E; Murakami Y; Imamura Y; Shay JW; Matsuura Y; Yokoyama T
    Clin Cancer Res; 2000 Jul; 6(7):2696-701. PubMed ID: 10914712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomere biology in neuroblastoma: telomere binding proteins and alternative strengthening of telomeres.
    Onitake Y; Hiyama E; Kamei N; Yamaoka H; Sueda T; Hiyama K
    J Pediatr Surg; 2009 Dec; 44(12):2258-66. PubMed ID: 20006006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia.
    Bechter OE; Eisterer W; Pall G; Hilbe W; Kühr T; Thaler J
    Cancer Res; 1998 Nov; 58(21):4918-22. PubMed ID: 9810000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of telomere-associated genes as prognostic markers for overall survival in patients with non-small cell lung cancer.
    Lin X; Gu J; Lu C; Spitz MR; Wu X
    Clin Cancer Res; 2006 Oct; 12(19):5720-5. PubMed ID: 17020976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomere length variation and maintenance in hepatocarcinogenesis.
    Yokota T; Suda T; Igarashi M; Kuroiwa T; Waguri N; Kawai H; Mita Y; Aoyagi Y
    Cancer; 2003 Jul; 98(1):110-8. PubMed ID: 12833463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomere length homeostasis requires that telomerase levels are limiting.
    Cristofari G; Lingner J
    EMBO J; 2006 Feb; 25(3):565-74. PubMed ID: 16424902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomere stability is frequently impaired in high-risk groups of patients with myelodysplastic syndromes.
    Ohyashiki JH; Iwama H; Yahata N; Ando K; Hayashi S; Shay JW; Ohyashiki K
    Clin Cancer Res; 1999 May; 5(5):1155-60. PubMed ID: 10353751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.